CardiOx Corporation

CardiOx Corp , based in Columbus, is commercializing a technology that enables a highly sensitive, low-cost, minimally invasive procedure for cardiac shunt assessment using their FDSTM Flow Detection System, which has received CE Mark approval with Europe and FDA regulatory clearance in the USA.

Additional Investors:
Ohio TechAngels, Early Stage Partners, Glengary LLC, LifeLine Ventures, Reservoir Venture Partners